Table 5.
Pathologic features in relation to predictive MR imaging findings
| Pathologic feature | Corona enhancement | Peritumoral hypointensity on HBP | Satellite nodule | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Absent | Present | p | Absent | Present | p | Absent | Present | p | |
| Tumor differentiation | 0.012 | 0.095 | 0.858 | ||||||
| Well or moderately differentiated | 45 (60.0) | 9 (32.1) | 45 (57.0) | 9 (37.5) | 48 (52.7) | 6 (50.0) | |||
| Poorly differentiated | 30 (40.0) | 19 (67.9) | 34 (43.0) | 15 (62.5) | 43 (47.3) | 6 (50.0) | |||
| Microvascular invasion | 0.490 | 0.004 | 0.870 | ||||||
| Absent | 56 (74.7) | 19 (67.9) | 63 (79.7) | 12 (50.0) | 67 (73.6) | 8 (66.7) | |||
| Present | 19 (25.3) | 9 (32.1) | 16 (20.3) | 12 (50.0) | 24 (26.4) | 4 (33.3) | |||
| Serosal invasion | 0.190 | 0.703 | 0.386 | ||||||
| Absent | 43 (57.3) | 12 (42.9) | 43 (54.4) | 12 (50.0) | 50 (54.9) | 5 (41.7) | |||
| Present | 32 (42.7) | 16 (57.1) | 36 (45.6) | 12 (50.0) | 41 (45.1) | 7 (58.3) | |||
| Satellite nodule | 0.107 | 0.247 | < 0.001 | ||||||
| Absent | 71 (94.7) | 23 (82.1) | 74 (93.7) | 20 (83.3) | 87 (95.6) | 7 (58.3) | |||
| Present | 4 (5.3) | 5 (17.9) | 5 (6.3) | 4 (16.7) | 4 (4.4) | 5 (41.7) | |||
| Cirrhosis | 0.465 | 0.050 | 0.978 | ||||||
| Absent | 45 (60.0) | 19 (67.9) | 45 (57.0) | 19 (79.2) | 56 (61.5) | 8 (66.7) | |||
| Present | 30 (40.0) | 9 (32.1) | 34 (43.0) | 5 (20.8) | 35 (38.5) | 4 (33.3) | |||
Data are number of patients with percentage in parentheses
HBP hepatobiliary phase, MR magnetic resonance